Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

NCT07266493 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Neoadjuvant Therapy

Interventions

DRUG: Chemotherapy （Albumin bound paclitaxel and Carboplatin）

Sponsor

Shanghai Zhongshan Hospital

Collaborators

[object Object]